The Ebola outbreak in the Democratic Republic of Congo (DRC) has surpassed 5,000 cases, with the World Health Organization (WHO) confirming the ongoing crisis as a global health emergency. Following an emergency meeting, WHO Director-General Tedros Adhanom Ghebreyesus called on the international community for assistance, warning that the epidemic is far from under control and that officials are still playing catch-up.
Congo Ebola Infections Surpass 5,000 as WHO Confirms Global Emergency
The outbreak has killed more than 2,320 people, according to recent figures reported by Aljazeera. This seventeenth outbreak in the DRC is the deadliest in the country’s history, exceeding the death toll recorded during the 2018 to 2020 outbreak. Aljazeera noted that the virus is spreading at an unprecedented speed, with many deaths occurring in locations that indicate unidentified chains of transmission.
Surveillance Gaps and Operational Challenges
Response efforts in eastern Congo face severe operational obstacles, including conflict in the mineral-rich region, misinformation, community distrust of health workers, and cultural traditions. According to reporting from AP News, between 60% and 70% of new Ebola cases are detected among individuals who were not previously monitored as known contacts. This surveillance gap means health workers often discover infections only after patients are already sick and have exposed others.
In Ituri province, Nizi has emerged as one of the most affected health zones, accounting for about 90% of Congo’s Ebola cases and 80% of its deaths. Community health workers in Nizi, such as Gédéon Banga Ngbape, handle an average of 60 to 70 alerts per day. However, local response efforts have suffered from strikes; health workers at the Nizi Treatment Center temporarily closed the facility after going more than three months without pay.
To help address funding constraints, U.N. humanitarian chief Tom Fletcher announced an additional $30.5 million in emergency funding.
Vaccine Limitations and Strain Characteristics
Complicating the response is the specific strain driving the current epidemic: Bundibugyo. Unlike some previous outbreaks, there is currently no approved vaccine or treatment available for this specific strain.
However, experimental vaccine developments are underway. The first volunteer to receive an experimental vaccine for the Bundibugyo strain received a jab in the UK, and hundreds of thousands of doses produced by scientists at Oxford University have been manufactured in India, ready for immediate deployment if ongoing trials prove successful.
Response Strategies and Regional Preparedness
Response teams are adapting their tactics to tackle community transmission. WHO medic Thierno Balde noted that motorbike riders have become a core focus of response efforts. Because these riders handle transport duties such as delivering patients and deceased bodies, they have been heavily affected. Officials are making hand-washing stations and disinfectant available while recruiting the riders as surveillance and response officers.
Regional health systems have also raised their guard. In Nigeria, the Nigeria Centre for Disease Control and Prevention (NCDC) announced that it is actively strengthening surveillance, ramping up laboratory readiness, infection prevention, and public awareness. Although Nigeria currently has no confirmed cases of Ebola Virus Disease, NCDC Director General Jide Idris emphasized the importance of maintaining vigilance across the public health system following the developments in the DRC.
